Examples of using Hiv in English and their translations into Urdu
{-}
-
Ecclesiastic
-
Colloquial
-
Computer
They know that you spoke with an HIV testing service and then your doctor and then your health insurance company in the same hour, but they don't know what you talked about?
Scientists have created medicines that stop the HIV from being dangerous but no one has found a
If you are living with HIV, just make sure you're not getting sicker, you're on antiretroviral medicines, and your health is otherwise good.
definitely know you have recently been exposed to HIV, tell your doctor.
At a time when many infectious diseases were being brought or kept under control with global vaccination efforts in the 1990s, the human immunodeficiency virus(HIV), only identified in 1984, infected millions worldwide.
the damage has already been done, and he fears some people with HIV will now refuse to seek treatment due to safety concerns.
Snorting, for instance, leads to destruction of nasal passages, amongst other problems, whereas IV injection- and the common practice of sharing needles- can transmit blood-borne pathogens, HIV and Hepatitis C(currently a national problem of epidemic proportions).
Robust evidence on the relative risks, particularly HIV susceptibility, and benefits of these contraceptive methods is important to inform women's decision making, provider counselling, and policy maker and regulatory decisions.
If there is a risk that the person who bit you might have hepatitis B, hepatitis C or HIV, you may be advised to have a blood test to check for these conditions.
Individuals with abnormal spleen function are at an increased risk for developing severe meningococcal disease. HIV infection and some genetic factors are also likely to increase the risk for meningococcal disease, as is cigarette smoking. Family members of an infected person also have an increased risk.
Raw Enfuvirtide powder is a 36 residue synthetic peptide that inhibits HIV-1 fusion with CD4 cells and is used with other anti-retrovirals for combination therapy of HIV INFECTIONS and AIDS, has a role as a HIV fusion inhibitor.
a couple of decades later, we had the arrival of HIV in the west and a very clear lesson about the ever-present danger of infectious diseases, which can spread very quickly from other parts of the world.”.
The push to end AIDS in the United States will concentrate on improving diagnosis, treatment, and prevention efforts in 48 counties; Washington, D.C.; and one municipality in Puerto Rico; those locations account for more than half of the nearly 40,000 new HIV diagnoses each year.
According to the WHO, 91 per cent of the world's population, or about seven billion people, breathe unhealthy air, which cuts short 7 million lives each year. Poor outdoor air quality alone causes 4.2 million deaths, more than those from malaria, tuberculosis and HIV/AIDS combined.
In this project, 22 local residents- called“journalists”- kept“conversational journals” that recorded, in detail, the conversations they overheard about AIDS in the daily lives of ordinary people(at the time the project began, about 15% of adults in Malawi were infected with HIV(Bello, Chipeta, and Aberle-Grasse 2006)).
Untreated active tuberculosis disease can be fatal. About 3% of people with untreated TB will die. This figure is much higher, however, when a person also has human immunodeficiency virus(HIV) infection. About 18% of people with active TB infection and HIV infection may die.
range of pharmaceuticals including, but not limited to, drugs for the treatment of high blood pressure, anti epilepsy medication, general anaesthetics, anti malarial drugs and even in the synthesis of HIV Medication.
A team of researchers at the University of Colorado are trying to modify the drugs to find a compound that will bind with the protease of SARS-CoV-2. There are criticisms within the scientific community about directing resources to repurposing drugs specifically developed for HIV/AIDS.
Many different groups are collaborating on these and other approaches to HIV vaccine development- perhaps more than for any vaccine development effort to date. Non-profit organizations, governments, pharmaceutical companies, philanthropic groups, and advocacy organizations are working together in what has become a truly global effort toward an HIV vaccine.
A 31% level of efficacy is not high enough to warrant use of a vaccine outside a trial setting, especially for a disease as serious as HIV. Yet this was the first time an HIV vaccine efficacy trial actually showed evidence of protection against the virus, giving researchers hope that an effective HIV vaccine is possible.